Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
270 | 3766 | 32.4 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
207 | 3 | MULTIPLE SCLEROSIS//MYASTHENIA GRAVIS//MULTIPLE SCLEROSIS JOURNAL | 52279 |
1365 | 2 | MYASTHENIA GRAVIS//THYMOMA//THYMIC CARCINOMA | 8240 |
270 | 1 | MYASTHENIA GRAVIS//THYMECTOMY//EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS | 3766 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MYASTHENIA GRAVIS | authKW | 6237250 | 37% | 56% | 1379 |
2 | THYMECTOMY | authKW | 1015102 | 7% | 50% | 249 |
3 | EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS | authKW | 392664 | 2% | 66% | 73 |
4 | ACETYLCHOLINE RECEPTOR ANTIBODY | authKW | 354830 | 2% | 72% | 61 |
5 | ACETYLCHOLINE RECEPTOR | authKW | 300143 | 5% | 20% | 190 |
6 | MYASTHENIC CRISIS | authKW | 221931 | 1% | 74% | 37 |
7 | THYMOMA | authKW | 187395 | 5% | 13% | 177 |
8 | MYASTHENIA | authKW | 181183 | 2% | 37% | 60 |
9 | SERONEGATIVE MYASTHENIA GRAVIS | authKW | 172929 | 1% | 89% | 24 |
10 | MUSCLE SPECIFIC KINASE | authKW | 155205 | 1% | 64% | 30 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 29069 | 39% | 0% | 1450 |
2 | Immunology | 10250 | 26% | 0% | 978 |
3 | Neurosciences | 8845 | 29% | 0% | 1109 |
4 | Respiratory System | 1006 | 5% | 0% | 182 |
5 | Surgery | 1000 | 11% | 0% | 407 |
6 | Medicine, General & Internal | 715 | 8% | 0% | 301 |
7 | Cardiac & Cardiovascular System | 242 | 4% | 0% | 169 |
8 | Pathology | 230 | 3% | 0% | 110 |
9 | Psychiatry | 208 | 4% | 0% | 144 |
10 | Ophthalmology | 149 | 2% | 0% | 89 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MULTIDISCIPLINARY MYASTHENIA GRAVIS UNIT | 40531 | 0% | 100% | 5 |
2 | UNIT MYASTHENIA GRAVIS | 40531 | 0% | 100% | 5 |
3 | NEUROL MED SERV | 33775 | 0% | 83% | 5 |
4 | NEUROL | 32673 | 27% | 0% | 1012 |
5 | NEUROSCI GRP | 30495 | 2% | 5% | 74 |
6 | NEUROIMMUNOL NEUROMUSCULAR DIS | 26524 | 0% | 55% | 6 |
7 | MYASTHENIA GRAVIS UNIT | 25939 | 0% | 80% | 4 |
8 | NEUROIMMUNOL DMSC | 25939 | 0% | 80% | 4 |
9 | AIM MYOL | 24319 | 0% | 100% | 3 |
10 | CHINA AFFILIATED HOSP | 24319 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROIMMUNOLOGY | 72767 | 7% | 4% | 246 |
2 | MUSCLE & NERVE | 26648 | 4% | 2% | 153 |
3 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 19733 | 8% | 1% | 313 |
4 | NEUROLOGY | 10977 | 5% | 1% | 171 |
5 | ACTA NEUROLOGICA SCANDINAVICA | 9998 | 2% | 1% | 87 |
6 | JOURNAL OF AUTOIMMUNITY | 7126 | 1% | 2% | 47 |
7 | AUTOIMMUNITY | 6776 | 1% | 2% | 42 |
8 | EUROPEAN JOURNAL OF NEUROLOGY | 5804 | 1% | 1% | 53 |
9 | JOURNAL OF THE NEUROLOGICAL SCIENCES | 5677 | 2% | 1% | 85 |
10 | AKTUELLE NEUROLOGIE | 4590 | 1% | 2% | 32 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MYASTHENIA GRAVIS | 6237250 | 37% | 56% | 1379 | Search MYASTHENIA+GRAVIS | Search MYASTHENIA+GRAVIS |
2 | THYMECTOMY | 1015102 | 7% | 50% | 249 | Search THYMECTOMY | Search THYMECTOMY |
3 | EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS | 392664 | 2% | 66% | 73 | Search EXPERIMENTAL+AUTOIMMUNE+MYASTHENIA+GRAVIS | Search EXPERIMENTAL+AUTOIMMUNE+MYASTHENIA+GRAVIS |
4 | ACETYLCHOLINE RECEPTOR ANTIBODY | 354830 | 2% | 72% | 61 | Search ACETYLCHOLINE+RECEPTOR+ANTIBODY | Search ACETYLCHOLINE+RECEPTOR+ANTIBODY |
5 | ACETYLCHOLINE RECEPTOR | 300143 | 5% | 20% | 190 | Search ACETYLCHOLINE+RECEPTOR | Search ACETYLCHOLINE+RECEPTOR |
6 | MYASTHENIC CRISIS | 221931 | 1% | 74% | 37 | Search MYASTHENIC+CRISIS | Search MYASTHENIC+CRISIS |
7 | THYMOMA | 187395 | 5% | 13% | 177 | Search THYMOMA | Search THYMOMA |
8 | MYASTHENIA | 181183 | 2% | 37% | 60 | Search MYASTHENIA | Search MYASTHENIA |
9 | SERONEGATIVE MYASTHENIA GRAVIS | 172929 | 1% | 89% | 24 | Search SERONEGATIVE+MYASTHENIA+GRAVIS | Search SERONEGATIVE+MYASTHENIA+GRAVIS |
10 | MUSCLE SPECIFIC KINASE | 155205 | 1% | 64% | 30 | Search MUSCLE+SPECIFIC+KINASE | Search MUSCLE+SPECIFIC+KINASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MERIGGIOLI, MN , SANDERS, DB , (2009) AUTOIMMUNE MYASTHENIA GRAVIS: EMERGING CLINICAL AND BIOLOGICAL HETEROGENEITY.LANCET NEUROLOGY. VOL. 8. ISSUE 5. P. 475-490 | 120 | 86% | 240 |
2 | MELZER, N , RUCK, T , FUHR, P , GOLD, R , HOHLFELD, R , MARX, A , MELMS, A , TACKENBERG, B , SCHALKE, B , SCHNEIDER-GOLD, C , ET AL (2016) CLINICAL FEATURES, PATHOGENESIS, AND TREATMENT OF MYASTHENIA GRAVIS: A SUPPLEMENT TO THE GUIDELINES OF THE GERMAN NEUROLOGICAL SOCIETY.JOURNAL OF NEUROLOGY. VOL. 263. ISSUE 8. P. 1473 -1494 | 123 | 75% | 2 |
3 | GOTTERER, L , LI, YB , (2016) MAINTENANCE IMMUNOSUPPRESSION IN MYASTHENIA GRAVIS.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 369. ISSUE . P. 294 -302 | 112 | 93% | 0 |
4 | GWATHMEY, KG , BURNS, TM , (2015) MYASTHENIA GRAVIS.SEMINARS IN NEUROLOGY. VOL. 35. ISSUE 4. P. 327 -339 | 117 | 85% | 2 |
5 | GILHUS, NE , VERSCHUUREN, JJ , (2015) MYASTHENIA GRAVIS: SUBGROUP CLASSIFICATION AND THERAPEUTIC STRATEGIES.LANCET NEUROLOGY. VOL. 14. ISSUE 10. P. 1023 -1036 | 78 | 90% | 28 |
6 | BINKS, S , VINCENT, A , PALACE, J , (2016) MYASTHENIA GRAVIS: A CLINICAL-IMMUNOLOGICAL UPDATE.JOURNAL OF NEUROLOGY. VOL. 263. ISSUE 4. P. 826 -834 | 79 | 86% | 5 |
7 | SATHASIVAM, S , (2011) CURRENT AND EMERGING TREATMENTS FOR THE MANAGEMENT OF MYASTHENIA GRAVIS.THERAPEUTICS AND CLINICAL RISK MANAGEMENT. VOL. 7. ISSUE . P. 313-323 | 93 | 92% | 7 |
8 | BERRIH-AKNIN, S , LE PANSE, R , (2014) MYASTHENIA GRAVIS: A COMPREHENSIVE REVIEW OF IMMUNE DYSREGULATION AND ETIOLOGICAL MECHANISMS.JOURNAL OF AUTOIMMUNITY. VOL. 52. ISSUE . P. 90 -100 | 87 | 64% | 50 |
9 | SILVESTRI, NJ , WOLFE, GI , (2012) MYASTHENIA GRAVIS.SEMINARS IN NEUROLOGY. VOL. 32. ISSUE 3. P. 215-226 | 76 | 97% | 23 |
10 | CAVALCANTE, P , LE PANSE, R , BERRIH-AKNIN, S , MAGGI, L , ANTOZZI, C , BAGGI, F , BERNASCONI, P , MANTEGAZZA, R , (2011) THE THYMUS IN MYASTHENIA GRAVIS: SITE OF "INNATE AUTOIMMUNITY"?.MUSCLE & NERVE. VOL. 44. ISSUE 4. P. 467-484 | 103 | 77% | 14 |
Classes with closest relation at Level 1 |